Medication uses CyDex technology
A drug-delivery compound with origins at Kansas University now is being used in medicine for treating schizophrenia and bipolar disorder.
CyDex Inc., a Lenexa-based pharmaceuticals company, announced Thursday that Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. were using CyDex’s Captisol technology – technology invented at KU’s Higuchi Biosciences Center – in an injection formulation of Abilify, an antipsychotic medication.
The U.S. Food and Drug Administration approved the Abilify injection Sept. 20.
City Government
City of Lawrence ‘assessing options’ in the wake of racist and antisemitic hate speech shared at recent commission meeting
City of Lawrence campsite reporting form has received 230 reports since October; only 57 campsites confirmed
City Commission meeting interrupted by racist, antisemitic hate speech
Lawrence City Commission set for light agenda this week
Campers who remain at North Lawrence site after closing date will be trespassed, but city doesn’t expect that to happen
